Total Results: 363
Health and Human Services Secretary Tom Price tells the Senate Finance Committee that President Donald Trump asked his department for recommendations on policies that would reduce the costs of medications.
The agency’s request to the medication’s drugmaker may signal a more aggressive approach against prescription opioids.
Biologist George Church may have narcolepsy, but he’s come to realize just how much he’s benefited from it. He thinks neurodiversity — like having autism or obsessive-compulsive disorder — can actually give people an edge in certain circumstances. In other public health news: breast cancer, lymph node removal, parenting, late-night snacks and a deadly drug in Georgia.
The company is selling its iNova Pharmaceuticals unit for $930 million, while Chief Executive Joseph Papa reiterates that Valeant is focusing on its core, which includes dermatology, eye care and gastrointestinal care.
Rep. Andy Harris (R-Md.) wants to shake up the agency by cutting indirect costs and using the savings to fund thousands of research projects instead. Meanwhile, scientists are wary of proposed federal funding caps for grants to individual labs.
Two Republican lawmakers talked to The Hill about the Rep. Chris Collins (R-N.Y.) conversations over stocks in an Australia-based pharmaceutical company.
One insurer is turning the tables on drugmakers with what may be a new job category: a sales force for cost-effective medicine.
Read recent commentaries about drug-cost issues.
News outlets report on stories related to pharmaceutical pricing.
The health organization is trying to counter the growing resistance humans have to antibiotics, which has created a world in which even the most minor of infections and illnesses can quickly turn deadly and in which diseases once thought conquered are becoming untreatable in more and more cases. In other public health news: chronic pain and dementia, what makes oncologists excited, and Legionnaires’ disease.
The substance, which people bought thinking it was Percocet, has not been identified, but officials said the street drug is “extremely potent and has required massive doses of naloxone to counteract its effects.’’ Media outlets report on the crisis out of Florida, Connecticut and California as well.
The House Energy and Commerce Committee is marking up a bill to renew the Food and Drug Administration’s authority to collect fees from the prescription drug and the medical device industries. In other news, next week the Senate Health, Education, Labor and Pensions Committee will also hold a hearing on drug costs.
Francis Collins enjoys widespread support from moderate Republicans despite being appointed during the previous administration.
With the cost of medications up 300 percent in the past decade, supporters see this as a first step to rein in prices.
Nurses who got the alerts from the patients at least once a week were able to adjust medication for nausea, constipation and pain, quicker than for those in the study who reported their symptoms during monthly oncologist meetings. The Washington Post offers a series of articles on cancer.
One in 9 Medicare enrollees have COPD and many of them can’t afford the inhalers that keep them out of the emergency room.
A congressional aide tells ProPublica that Health and Human Services Secretary Tom Price, while still in Congress in 2016 and visiting Australia, put pressure on officials there to change their position so that drugmakers could keep their data protected for 12 years instead of five.
Health officials announced a public-private partnership that aims to more rapidly bring drugs related to treating those addicted to opioids to market. Meanwhile, Express Scripts is suing a drugmaker over its overdose medication, a look at how one letter to the editor helped shape the course of an epidemic, and more from the opioid crisis.
Ohio has been hard hit by the opioid epidemic and the state’s Attorney General Mike DeWine wants pharmaceutical companies to take some responsibility for it.
The analysis by the inspector general’s office at the Department of Health and Human Services “should worry every taxpayer,” the Iowa senator said.